Advisors Asset Management Inc. Increases Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Advisors Asset Management Inc. increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.9% during the third quarter, HoldingsChannel.com reports. The fund owned 30,442 shares of the biotechnology company’s stock after acquiring an additional 850 shares during the quarter. Advisors Asset Management Inc.’s holdings in Axon Enterprise were worth $12,165,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. 1832 Asset Management L.P. grew its holdings in Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock valued at $110,546,000 after purchasing an additional 114,800 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in Axon Enterprise by 13.9% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock valued at $108,496,000 after acquiring an additional 45,049 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in Axon Enterprise by 1.6% in the 2nd quarter. Thrivent Financial for Lutherans now owns 270,430 shares of the biotechnology company’s stock valued at $79,571,000 after acquiring an additional 4,365 shares during the last quarter. Federated Hermes Inc. increased its holdings in Axon Enterprise by 14.5% during the 2nd quarter. Federated Hermes Inc. now owns 234,185 shares of the biotechnology company’s stock valued at $68,907,000 after acquiring an additional 29,680 shares in the last quarter. Finally, Hood River Capital Management LLC raised its position in Axon Enterprise by 5.2% during the second quarter. Hood River Capital Management LLC now owns 224,850 shares of the biotechnology company’s stock worth $66,160,000 after acquiring an additional 11,126 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Up 1.7 %

AXON stock opened at $610.20 on Wednesday. Axon Enterprise, Inc. has a 52 week low of $224.16 and a 52 week high of $624.84. The company has a market cap of $46.53 billion, a price-to-earnings ratio of 157.67, a PEG ratio of 15.05 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $448.52 and a 200-day simple moving average of $361.95.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 70,000 shares of Axon Enterprise stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $362.21, for a total value of $25,354,700.00. Following the transaction, the chief executive officer now directly owns 2,945,366 shares of the company’s stock, valued at $1,066,841,018.86. The trade was a 2.32 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, President Joshua Isner sold 20,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 410,556 shares of company stock valued at $161,192,754. Company insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on AXON. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Robert W. Baird increased their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Barclays boosted their price target on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, Northland Securities boosted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.